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Abstract
Background: A variety of forces are now shaping a passionate debate regarding the optimal approaches to
improving the quality of substance abuse services for American Indian and Alaska Native communities. While there
have been some highly successful efforts to meld the traditions of American Indian and Alaska Native tribes with
that of 12-step approaches, some American Indian and Alaska Natives remain profoundly uncomfortable with the
dominance of this Euro-American approach to substance abuse treatment in their communities. This longstanding
tension has now been complicated by the emergence of a number of evidence-based treatments that, while
holding promise for improving treatment for American Indian and Alaska Natives with substance use problems,
may conflict with both American Indian and Alaska Native and 12-step healing traditions.
Discussion: We convened a panel of experts from American Indian and Alaska Native communities, substance
abuse treatment programs serving these communities, and researchers to discuss and analyze these controversies
in preparation for a national study of American Indian and Alaska Native substance abuse services. While the panel
identified programs that are using evidence-based treatments, members still voiced concerns about the cultural
appropriateness of many evidence-based treatments as well as the lack of guidance on how to adapt them for use
with American Indians and Alaska Natives. The panel concluded that the efforts of federal and state policymakers
to promote the use of evidence-based treatments are further complicating an already-contentious debate within
American Indian and Alaska Native communities on how to provide effective substance abuse services. This
external pressure to utilize evidence-based treatments is particularly problematic given American Indian and Alaska
Native communities’ concerns about protecting their sovereign status.
Summary: Broadening this conversation beyond its primary focus on the use of evidence-based treatments to
other salient issues such as building the necessary research evidence (including incorporating American Indian and
Alaska Native cultural values into clinical practice) and developing the human and infrastructural resources to
support the use of this evidence may be far more effective for advancing efforts to improve substance abuse
services for American Indian and Alaska Native communities.
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Focus of this debate
Despite concerted efforts to improve alcohol and drug
abuse prevention and clinical programs as well as dec-
ades of research, available information suggests that the
prevalence of problematic substance use has not appre-
ciably changed in many American Indian and Alaska
Native (AI/AN) communities [1-4]. While the specific
contexts, patterns, and severity of these difficulties do
vary across AI/AN communities [5-9], the overall rates
of problematic substance use [1,2,4,5,7,8] and related
morbidity and mortality [10-12] are comparable to - or
far exceed - the rates of non-AI/ANs.
Given this, an effective substance abuse treatment sys-
tem is critical to address these needs in AI/AN commu-
nities. Unfortunately, while dedicated clinicians, clinical
programs, tribes, and the Indian Health Service (IHS)
have developed some highly innovative treatment
approaches in many AI/AN communities [13-18], such
services remain severely underfunded and many AI/AN
communities still have limited access to substance abuse
treatment services [19,20]. Indeed, epidemiological stu-
dies confirm that only a small percentage of those parti-
cipants with substance use disorders received substance
abuse treatment [21].
A variety of forces, both internal and external to AI/
AN communities, are now shaping a passionate debate
regarding the optimal approaches to improving the qual-
ity of this substance abuse service system. Changes in
federal policy dating to the Nixon administration have
provided AI/AN communities much greater autonomy
in developing and implementing a variety of services -
including substance abuse services - independent of fed-
eral oversight [22]. This is coupled with a groundswell
of interest in applying the healing traditions that are
integral to AI/AN cultures to address substance use and
related problems [14,23-27]. Nevertheless, many sub-
stance abuse programs serving AI/AN communities
continue to draw upon 12-step approaches that were
originally introduced when funds for such programs
were first made available in the United States in the
1960s and 1970s [27-30]. While there have been some
highly successful efforts to meld the traditions of AI/AN
tribes with that of 12-step approaches [31,32], some AI/
ANs remain profoundly uncomfortable with the domi-
nance of this Euro-American approach to substance
abuse services in their communities [27,33]. This long-
standing tension has now been compounded by the
emergence of a number of evidence-based treatments
(EBTs; described further below) [34] that, while holding
substantial promise for improving services for AI/ANs
with substance use problems (as they do for non-AI/
ANs), may conflict with both AI/AN and 12-step heal-
ing traditions and may be seen as yet another imposition
of alien approaches in AI/AN programs. Reinforcing
these concerns is the fact that AI/ANs have rarely parti-
cipated in the clinical trials to establish the efficacy of
these EBTs, in part because of their reluctance to do so
because of a history of substantial research abuses
[33,35] as well as serious questions regarding the value
of research for improving circumstances for AI/AN peo-
ple [36,37]. This lack of evidence and longstanding wari-
ness of research further contributes to the hesitancy of
programs serving AI/AN communities to implement
these treatments [33,38]. Efforts of policymakers to
encourage (and sometimes require) the use of these
EBTs in programs receiving federal and state funding
[39,40] are further intensifying this debate.
Our research team is interested in studying how EBTs
are perceived and used (or not used) by substance abuse
programs serving AI/AN communities. However, as we
prepared to start this investigation, it became clear from
both our conversations with key stakeholders and our
review of recent publications that this debate has
become so contentious that we needed to address these
issues squarely in the design of our research. We there-
fore convened an advisory board for a three-day meeting
in September 2008 to discuss these controversies, how
these controversies might threaten our data collection
efforts, and methods to reduce the risks of these threats
to our project. Along with our original team of Univer-
sity-based researchers (with expertise in clinical, cul-
tural, and epidemiological sciences), our Advisory Board
consists of experts from substance abuse programs ser-
ving AI/AN communities working in clinical, adminis-
trative, evaluative, and policymaking capacities. These
experts were invited to participate based on their repu-
tations for having pursued the development of high
quality substance abuse services for AI/AN communities
at the local, regional, and national levels while at least
partially representing the geographic and cultural diver-
sity of AI/AN communities. A subset of the Advisory
Board then pursued the completion of this manuscript
using an iterative process in which we referred to
detailed meeting notes, reviewed additional literature for
incorporation in the manuscript beyond that identified
during the meeting, and engaged in an ongoing ‘discus-
sion’ consisting of email exchanges as well as use of
Microsoft Word’s comments and track changes func-
tions on serial drafts of the manuscript until we felt we
had fully captured the original discussion and its impli-
cations. This subset of the Advisory Board are the
authors of the manuscript. All Advisory Board members
were given the opportunity to review and comment
upon final drafts of the manuscript prior to its submis-
sion (and resubmissions). This paper is a summary of
these discussions and addresses the following areas:
additional background regarding the specific
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a description of the key lines of tension around
approaches to substance abuse services in AI/AN com-
munities; and a discussion regarding specific concerns
about the use of EBTs in programs serving AI/AN com-
munities and their likely influence on the dissemination
process.
Community, policy, and practice contexts
Community contexts
A I / A N sa r ead i v e r s ea n dh e t e r o g e n e o u sp o p u l a t i o n .
There are over 560 federally recognized tribes in a
population that numbered nearly 2.5 million in 2000;
over 4 million if people listing AI/AN in conjunction
with other races are included [41]. The majority of the
AI/AN population resides in the western United States,
and is, on average, younger, less educated, and poorer
than the U.S. general population [41-43]. While a
greater percentage of the AI/AN population resides in
rural areas than the U.S. general population (34% versus
21%), the majority of AI/ANs now reside in urban/sub-
urban areas [44].
Also notable - after centuries of repression - is the
resurgence in community interests in tribal languages
and traditions, including traditional healing [26,33],
though engagement in and identification with AI/AN
and the majority culture vary considerably from indivi-
dual to individual and community to community [45].
Recent research suggests that many AI/ANs rely on tra-
ditional healing to address alcohol, drug, and mental
health problems, both independently and in combina-
tion with treatments emerging from Euro-American tra-
ditions [25]
a. Indeed, some authors have advocated a
greater reliance on traditional healing to address these
mental health and substance use problems and express
considerable skepticism about the utility of Euro-Ameri-
can-based treatments and the research methods used to
develop them noting that some AI/AN academicians,
service providers, and community members feel they
represent another form of colonialism that is harming
rather than helping AI/AN people and communities
[46].
Policy contexts
In order to understand the substance abuse service sys-
tem in AI/AN communities, it is helpful to start with its
unique funding and service delivery mechanisms, which
have undergone radical changes in recent years. Since
1955, the IHS has developed a health care system for
AI/AN communities at no cost to those eligible. Hospi-
tals and clinics are operated either by the IHS or by
tribes.
Recent changes to this system are largely the result of
the Indian Self-Determination and Educational Assis-
t a n c eA c t( P u b l i cL a w9 3 - 6 3 8 ) ,w h i c hh a sg i v e n
participating AI/AN tribes greater flexibility and auton-
omy to restructure human services. Indeed, substance
abuse services have long been at the cutting edge of the
trend towards greater tribal control of human services
with the majority of programs operated by tribes and
non-governmental tribal entities (such as urban Indian
health boards) [22,47] rather than the IHS. Unfortu-
nately, these policy changes have occurred concurrently
with substantial declines in what was already inadequate
funding. Funds for health care in AI/AN tribes, adjusted
for medical inflation and population growth, saw steady
declines throughout the 1990s [48]. This trend has con-
tinued over the last decade [47,49]. Even a record
increase for IHS in 2001 was barely sufficient to keep
up with medical inflation in that year [50-52]. The
National Indian Health Board reported that per capita
benefits for those AI/ANs receiving IHS-supported ser-
vices is one-half of that for Medicaid beneficiaries and
one-third of that for Veterans Affairs beneficiaries [53].
The US Civil Rights Commission has echoed these con-
cerns [51,52]. Also troubling is the fact that funding for
health services for AI/ANs has not kept pace with
demographic trends. Urban Indian health boards, which
were chartered by the IHS, receive very limited funding
(about 1% of the IHS budget) even though the majority
of AI/AN people now live in urban and suburban areas
[44,54] (unpublished data, National Center for Urban
Indian Health).
Understandably, programs serving AI/AN commu-
nities have responded to these real declines in funding
by seeking out other sources of programmatic support.
For example, the Substance Abuse and Mental Health
Services Administration’s (SAMHSA) Center for Sub-
stance Abuse Treatment (CSAT) has awarded more
grants in recent years to tribes, tribal consortiums, and
urban Indian health boards than has been typical in the
past [55]. Some tribes have aggressively pursued Medi-
caid and third party reimbursement for health services
(including behavioral health) [50,56]. In Arizona, three
tribes (Gila River, Navajo, and Pascua Yaqui) function
as Tribal Regional Behavioral Health Authorities, thus
serving as their own Medicaid-funded behavioral health
programs [57]. All of these funders are also moving
towards requiring EBTs for grant funding and reimbur-
sement for clinical services. For example, CSAT now
requires that grant applicants specify the EBTs they will
use for services supported through these funds, and the
Oregon Health Plan is phasing in an EBT requirement
for all health services, including substance abuse ser-
vices [39,40,58]. Given these emerging requirements for
EBT use, we expect that many AI/AN programs are
developing ways to respond to these requirements,
although the nature of these responses are largely
unknown.
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b
The substance abuse service system for AI/AN commu-
nities emerged out of the same federal efforts of the
1960s and 1970s that shaped their counterparts in the
rest of the United States [30]. Although the develop-
ment of the service system for AI/AN communities was
managed somewhat separately from that for the rest of
the United States - substance abuse programs were
transferred from the National Institute of Alcohol
Abuse and Alcoholism to the IHS in 1978 [59], and the
training of counselors for these programs was (and is)
often done through special training programs (e.g.,t h e
Southwest Certification Board) [60], the programs that
emerged similarly relied on a cadre of counselors who
were trained to utilize treatment models that grew out
of the 12-step movement [30].
Some believe the legacy of 12-step-trained counselors
and 12-step-based treatments has impeded the accep-
t a n c ea n du s eo fE B T si ns u b s t a n c ea b u s ep r o g r a m s
across the United States [61]. What is particularly nota-
ble, and distinct, about the development of the sub-
stance abuse service system in AI/AN communities was
t h ec o n s i d e r a b l er e s i s t a n c et o1 2 - s t e pa p p r o a c h e st o
treatment, particularly from those AI/ANs most strongly
connected to their Native cultures [62]. These commu-
nity members felt 12-step approaches conflicted with
their traditional beliefs, and it took a concerted effort by
AI/ANs such as Earl L., Gene Thin Elk, and Don Coyhis
to adapt these approaches for AI/ANs and to advocate
for their use [31]. While some AI/ANs remain uncom-
fortable with 12-step approaches, these efforts have
resulted in large-scale acceptance of 12-step treatments
in AI/AN communities, though this is in the context of
a strong emphasis on combining 12-step and traditional
AI/AN practices [31].
The IHS website lists 480 behavioral health programs
serving AI/AN communities [63], but there are no reliable
surveillance data regarding the nature and scope of sub-
stance abuse services for AI/ANs and questions about the
quality of behavioral health services for AI/ANs remain
[22,64]. Novins et al.’s detailed study of AI adolescents
admitted to a residential substance abuse program pro-
vides the most rigorously collected data [29,65]. Results
show that while this particular program uses a 12-step fra-
mework for its services, it also includes a traditional heal-
ing component, utilizes cognitive behavioral therapy, and
offers pharmacotherapy for comorbid non-substance use
psychiatric disorders. It is unclear, however, if such blend-
ing of treatment approaches is common in substance
abuse programs serving AI/AN communities.
Evidence-based treatments for substance abuse problems
EBTs for substance abuse treatment can be divided into
two broad categories, psychosocial and pharmacologic.
Psychosocial treatments are largely based on behavioral
and cognitive-behavioral theoretical models. Behavio-
rally-based treatments such as Contingency Manage-
ment [66] rely on principles of operant conditioning to
provide positive reinforcement (i.e., rewards) for pro-
gress in treatment (most typically abstinence from sub-
stance use). Psychosocial treatments are typically
provided by a psychotherapist in individual, couples,
family, and group settings. The number of sessions vary
considerably across EBTs, with some involving as few as
two sessions (e.g., Motivational Interviewing [67]) while
others involve as many as 15-20 sessions (e.g., Behavioral
Couples Therapy [68] and Relapse Prevention Therapy
[69]. Pharmacologic treatments for substance use pro-
blems involve the use of medications for the treatment
of withdrawal syndromes in the initial stage of stopping
the chronic use of an addictive substance (including
alcohol and opiods), [70] medication to reduce the risk
of relapse [71], and medications to treat comorbid psy-
chiatric conditions that may contribute to substance
related problems (including mood disorders such as
Major Depression) [72,73]. See Table 1 for a list of
selected EBTs for substance use problems.
Lines of tension around substance abuse services for AI/
AN communities
Figure 1 represents the key lines of tension our Advisory
Board identified around the use of EBTs in substance
abuse programs serving AI/AN communities. The two
Euro-American sets of practices, 12 step and EBTs, now
form the basis of most substance abuse services offered
in the United States, and the tensions between them
have been described previously [61]. For example, the
landmark 1998 Institute of Medicine (IOM) report
‘Bridging the Gap Between Practice and Research: For-
ging Partnerships with Community-Based Drug and
Alcohol Treatment’ [28] identified a number of factors
that the authors felt impeded the transfer of knowledge
between researchers and clinical programs. These fac-
tors included those related to research (e.g., the study of
interventions that were impractical in real-life settings),
clinical practice (e.g., negative attitudes towards
research), and policy (e.g.,p o l i c i e st h a tb a rt h eu s eo f
specific EBTs) [28]. Indeed, many of CSAT’s, National
Institute of Alcohol Abuse and Alcoholism’s (NIAAA),
and National Institute of Drug Abuse’s( N I D A )e f f o r t s
to promote the use of EBTs, including CSAT’s Addic-
tion Technology Transfer Centers [74,75] and NIDA’s
‘Clinical Trials Network,’ [76,77] were a direct response
to the findings and recommendations of this and other
reports.
Given the historical roots of substance abuse programs
in AI/AN communities described above, these tensions
and the national efforts to address them are clearly
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towards and use of EBTs. However, it is also important
to account for the considerable tensions between the
two Euro-American practices and practices that emerge
from AI/AN traditions. Several decades of experience
have allowed the AI/AN substance abuse treatment
community to address the tensions between 12-step
practices and AI/AN practices (and have resulted in sev-
eral innovative approaches noted previously). However,
efforts to promote the use of EBT’s are relatively new,
and the range of responses by substance abuse programs
serving AI/AN communities is largely unknown. Given
our collective experiences in working with a number of
these programs, we expect that there is a considerable
range of responses, including wholesale adoption of
EBTs with minimal adjustments to account for 12-step
and AI/AN traditional practices, selective adoption of
specific elements of EBTs which are melded with 12-
step and/or AI/AN practices, and ongoing resistance to
the use of EBTs in any form.
Further complicating the incorporation of EBTs into
these substance abuse programs are basic questions that
some AI/AN academics and service providers have
regarding the validity and ultimate value of the scientific
process when applied to the needs of their communities,
seeing this as another imposition of non-AI/AN world-
views on their communities [26,36,78,79]. Indeed, tribes,
tribal organizations, and organizations representing
other diverse communities have successfully pressed for
changes in the language regarding EBTs in CSAT grant
announcements [80] as well as an alternative, non-EBT
pathway for approval of AI/AN treatments for Medicaid
reimbursement in Oregon [81]. These efforts can be
linked to a larger, ‘Practice-Based Evidence Movement,’
[82] which emphasizes the value of systematic evalua-
tion of interventions within community practice settings
and is usually described as a complement of [82] - and
sometimes as an alternative to [26,79] - EBTs. In AI/AN
communities, the Practice-Based Evidence movement
further emphasizes that AI/ANt r e a t m e n t ss h o u l dh a v e
primacy over EBTs, and that such Euro-American treat-
ments should be integrated into AI/AN treatments
rather than the reverse [26,79].
However, others have suggested that there are impor-
tant parallels between the scientific process and tradi-
tional AI/AN ways of understanding themselves and the
world around them (something that has been proposed
by several scholars for indigenous people more generally
[83]); others have suggested that there is value in har-
nessing the scientific process for the benefit of AI/AN
people [84]. Indicative of the complexity of community
sentiments regarding science are the facts that members
of our Board are personally working with several com-
munities to develop manualized interventions for test-
ing, and at least two AI/AN programs participate in
Table 1 Selected examples of evidence-based treatments for substance use problems
Evidence-based treatment Brief description and citation
Psychosocial Treatments - Behavioral
￿ Contingency
management
Provide positive reinforcement (i.e., rewards) for progress in treatment (most typically abstinence from
substance use) [66].
Psychosocial Treatments - Cognitive Behavioral
￿ Motivational interviewing/motivational
enhancement therapy
Focuses on facilitating behavioral change by helping individuals to explore and resolve ambivalence
towards treatment and become committed to addressing their substance use problems [67].
￿ Behavioral couples therapy Focuses on building an abstinence-supporting relationship between the person who is abusing
substances and his or her partner [68].
￿ Relapse prevention therapy Teaches individuals with substance addiction a number of specific skills to reduce the risk of relapse
[69].
Pharmacologic Treatments
￿ Medication for relapse
prevention
The use of medications to help prevent relapse of substance use problems, such as naltrexone,
methadone, and buprenorphine [71].
Figure 1 Lines of tension in substance abuse services for
American Indian/Alaska Natives. This list of treatments, generated
by our Advisory Board, provides a partial listing of traditional
American Indian/Alaska Native treatments. These practices are
typically named in the tribal languages; specific procedures also vary
across tribes.
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these situations, the barriers for the effective use of
EBTs are likely substantial. We will now consider those
we expect are likely to be particularly salient.
Discussion of specific concerns regarding the use of EBTs
in programs serving AI/AN communities
Based on our review of the available literature and our
experiences in the field, we identified a number of issues
that we felt were likely impacting attitudes towards, and
u s eo f ,E B T si ns u b s t a n c ea b u s ep r o g r a m ss e r v i n gA I /
AN communities. We then classified these issues based
on Greenhalgh et al.’s [86] summary of the factors asso-
ciated with the successful dissemination of innovations
into clinical practice. These factors were subsequently
highlighted in the Institute of Medicine’sr e p o r t
‘Improving the Quality of Health Care for Mental and
Substance-Use Conditions’ [87] and provide a useful
rubric for classifying the issues we identified and for dis-
cussing the impacts we hypothesize they are having on
the use of EBTs in these substance abuse programs. The
most relevant factors are discussed below and summar-
ized in Table 2.
Characteristics of the innovation
Our group concluded that the characteristics of many of
the EBTs themselves and their potential lack of fit with
the values of providers and the communities they serve
[88] are likely a major factor in limiting their dissemina-
tion to substance abuse programs serving AI/AN com-
munities. In particular, we believe there is a strong
perception that many EBTs are not in and of themselves
culturally appropriate for use with AI/ANs. The lack of
a spiritual component to the vast majority of EBTs - a
core component of 12-step approaches that has likely
contributed to their successful adaptation for use in AI/
Table 2 Factors associated with dissemination of innovations and how these factors likely influence use of EBTs
a
Factor Likely Direction of
Influence
b
Characteristics of the innovation. Innovation more likely to be adopted if it:
￿ Is compatible with adopters’ values, norms, needs. ↓↓↓
￿ Is simple to implement. ↓↓
￿ Can be adapted, refined, modified for adopters’ needs. ↓↓↓
￿ Is accompanied by easily available or provided knowledge required for its use. ↓↓↓
Sources of communication and influence. Uptake of innovation influenced by:
￿ Structure and quality of social and communication networks. ↓
￿ Similarity of sources of information to targeted adopters; e.g., in terms of socioeconomic, educational, professional,
and cultural backgrounds.
↓
External influences. Uptake of innovation influenced by:
￿ Policy mandates. ↑↓ (attitudes), ↑↑↑ (use)
Linkages among the components. Innovation more likely to be adopted if there are:
￿ Formal linkages between developers and users early in development. ↓↓↓
￿ Effective relationships between any designated “change agents” and targeted adopters. ↓
Characteristics of individual adopters
￿ General and context-specific psychological traits. ↑↓
￿ Finding the intervention personally relevant. ↑↓
Structural and cultural characteristics of potential organizational adopters. Innovation more likely to be adopted if
organization:
￿ Has effective data systems. ↓↓
￿ Is “ready” for change because of ...available time and resources for change, and capacity to evaluate innovation’s
implementation.
↓↓↓
The uptake process. Innovation more likely to be adopted with:
￿ Funding. ↓↓↓ (Tribal/IHS), ↑↑↑ (EBT-
specific)
￿ Adaptation and reinvention. ↓↓↓
Programmatic Priorities. Innovation more likely to be adopted if it:
c
￿ Is consistent with the programmatic priorities of the adopter.
c ↓↓
Notes.
alist adapted from that developed by Greenhalgh et al., 2004 [86].
blikely direction of influence refers to our perceptions of how these particular factors are affecting the dissemination process in substance abuse treatment
programs serving AI/AN communities as follows: ↑↑↑ - strongly supportive of the dissemination process; ↑↓ - mixed/neutral; ↓ - somewhat negative; ↓↓ - negative;
↓↓↓ - strongly negative.
can additional factor identified by our Advisory Board but not included in Greenhalgh et al.’s summary.
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their use. An additional concern is that many EBTs are
too rigid to support implementation in substance abuse
programs with limited human, infrastructural, and finan-
cial resources.
Cultural adaptation of EBTs to better match consumer
and community preferences and programmatic adapta-
tion to better match programmatic capabilities were
issues the Advisory Board often returned to in our dis-
cussion. While such adaptations seem a particularly
compelling approach to increasing the likelihood of the
use of EBTs, the success of such approaches in the
available literature for behavioral health interventions is
mixed at best, with some successes reported [89,90], but
also some failures [91,92]. Indeed our Board noted two
contrasting examples in this regard. Multisystemic Ther-
apy and Strategies, in which research identified the
importance of maintaining intervention fidelity to assure
its effectiveness [93] led its developers to design a disse-
mination model that provides intensive training and
ongoing supervision of clinicians [94]. In contrast, Moti-
vational Interviewing has been subject to some research
and several program development efforts to develop cul-
turally-adapted manuals and treatment guidelines for
use with AI/ANs [17,95]. However, Motivational Inter-
viewing was perceived as a rare exception in this regard.
Indeed, our Board is encouraged by the growing body of
literature focused on identifying ‘core elements’ of EBTs
that are important to retain to maintain their effective-
ness [96-98]. Such research offers great promise for
guiding thoughtful adaptation efforts and our Board
recommended that these efforts should be extended to
include AI/AN communities.
In the end our Board hypothesized that the lack of
dissemination of clear, written guidance, or easily under-
stood process models about how to effectively adapt
most EBTs for these programs and communities
decreases the likelihood of their use. Indeed, while we
believe emerging models for cultural adaption of inter-
ventions may be useful for programs serving AI/AN
communities [89,99], we concluded that these core char-
acteristics of EBTs themselves present major challenges
for their use in programs serving AI/AN communities.
Sources of communication and influence
While our group did not identify this as a major issue
for substance abuse programs serving AI/AN commu-
nities, it is certainly true that most of these programs
have historically operated in an environment geographi-
cally, organizationally, and socially isolated from clinical
programs serving other communities in the United
States. Clinical programs serving AI/AN communities
have had unique funding sources, training programs
that have focused on the needs of AI/AN providers,
certification boards, and their own networks of meetings
and publications. The One Sky Center was funded by
SAMHSA to function as an Addiction Technology
Transfer Center specifically for programs serving AI/AN
communities (though this funding was ultimately dis-
continued, the Center continues to operate as part of
the Oregon Health and Sciences University [100]).
While we believe this separation has eroded in recent
years, it has not entirely disappeared and likely reduces
the opportunity of programs to learn about and consider
new, emerging EBTs.
External influences
As we discussed previously, the mandates for use of
EBTs by a variety of funders has created considerable
controversy within the AI/AN substance abuse treat-
ment community. While this has contributed to a highly
charged environment that creates significant challenges
for research in this area, more and more substance
abuse programs are seeking funding that brings with it
requirements to use EBTs. Funding is generally seen as
one of the most important but least changeable factors
impacting EBT implementation [101]. Therefore, we
expect these mandates are increasing the use of EBTs in
these programs while creating both positive and negative
attitudes towards their use.
Linkages among the components
Here Greenhalgh et al. [86] are referring to the connec-
tions between developers and users of the innovation.
As was the case for sources of communication and
influence, we expect that the historical separation of AI/
AN clinical programs makes such linkages less likely,
and this results in a negative influence on both attitudes
towards and use of EBTs. As we noted previously, we
do believe that a handful of programs are participating
in intervention research projects, but we suspect that
these are the exception rather than the rule.
Characteristics of individual adopters
As with substance abuse programs in general, the char-
acteristics of organizational leaders and front-line clini-
cians are likely quite variable in programs serving AI/
AN communities. For example, in some programs we
are familiar with, the organizational leaders are sub-
stance abuse professionals. In other programs, however,
these leadership positions may be filled by individuals
with strong political connections but limited expertise in
substance abuse services. Similarly, the educational
levels, training, and experience with manualized treat-
ments among front-line clinical staff is likely variable as
well. Given the evidence that local leadership at the
clinic or team level, along with providers’ education
level, experience, and level of professional development
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[102,103], these variations no doubt influence the use of
EBTs in individual programs. Indeed, our Board expects
that workforce issues are one of the major barriers to
the use of EBTs in these programs. However, because
we believe the variability in individual adopter character-
istics across programs is likely substantial, their overall
impact for programs serving AI/AN communities is dif-
ficult to predict.
Structural and cultural characteristics of potential
organizational adopters
Critical here are programmatic resources - human,
infrastructural (including information technology), and
fiscal - that are necessary to learn about EBTs and
receive the necessary training for their use as well as the
tools to implement them and evaluate their impact.
Given that many programs serving AI/AN programs are
severely constrained in these areas, we expect that these
factors have a strong negative influence on both atti-
tudes towards and use of EBTs.
The uptake process
The current uptake process likely has a mixed impact
on attitudes towards and use of EBTs in substance
abuse programs serving AI/AN communities. As noted
above, the real declines in IHS funding likely have a
strong negative impact on the use of EBTs as the result-
ing human and infrastructural limitations make it diffi-
cult to implement and evaluate EBTs. In contrast, the
availability of EBT-focused funding likely has a strong
positive impact, at least among the programs that suc-
cessfully compete and/or qualify for these funds. Even
with increased funding, the perceived inflexibility of
these EBTs and lack of guidance regarding their adapta-
tion likely have a strong negative influence on the disse-
mination process.
Programmatic priorities
Finally, our group identified an additional factor that did
not easily fit into the Greenhalgh et al. [86] framework -
that the focus on EBTs is likely perceived as misplaced
by many individuals and programs working in this area
as it potentially neglects some of the basic foundations
for quality substance abuse clinical services. These foun-
dations include effective workforce development and
stability, well-designed (and maintained) facilities, a
modern information technology infrastructure, and
improved access to services for community members in
need. There are very few programs that have active con-
sumer- or community advocate-involvement. Thus, we
hypothesize that EBTs are of lower priority for these
substance abuse programs given these other challenges
they face in maintaining the services they currently
provide. This likely has a strong negative influence on
the dissemination process.
In summary, we believe that the vast majority of these
factors - particularly those that are internal to these sub-
stance abuse programs - are likely limiting the dissemi-
nation of EBTs to substance abuse programs serving AI/
AN communities. And it is primarily external factors -
those of policy and funding - that are likely facilitating
the dissemination process.
O u ra n a l y s i sp r o v i d e sap r e liminary explanation for
the strong sense of concern and controversy we encoun-
tered as we began our investigation. Indeed, given the
sovereign status of tribes and their power to make deci-
sions for their communities, a substantial reliance on
external factors for promoting dissemination is, at best,
seriously flawed as a strategy for effective dissemination.
Summary
The controversy around EBTs and substance abuse ser-
vices for AI/ANs is concerning for many reasons. Per-
haps of most importance is that this controversy is
creating divisions among key stakeholders that should
be more strongly aligned if we are to improve the qual-
ity of services for AI/ANs with substance use problems.
The initiatives to increase the use of EBTs in substance
abuse programs have certainly grown out of a strong,
nationwide and multidisciplinary desire to improve the
quality of services provided to Americans with substance
use problems. While the goals of these efforts are cer-
tainly laudatory, the unique community, policy, and
practice contexts that appear to complicate these efforts
in AI/AN communities have yet to be adequately
explored. Indeed, in our conversations we were all
s t r u c kb yt h ef a c tt h a tt h ep e r c e i v e df o c u so ft h e s e
efforts is to promote EBTs rather than Evidence-Based
Practice - the integration of best research evidence with
clinical expertise and patient values [104]. An explicit
shift to promoting evidence-based practice rather than
EBTs might allow for a broader and more constructive
conversation around improving the quality of substance
abuse services in AI/AN communities. Indeed, broaden-
ing the conversation to include building the necessary
research and practice evidence, developing the human,
infrastructural, and fiscal resources to support the use of
this evidence, and more careful thought about incorpor-
ating patient (and AI/AN cultural) values into clinical
practice, may be far more attractive - and much less
controversial - than the current approach. For example,
careful consideration of the implications of the unique
patterns of substance use in specific AI/AN commu-
nities, such as the high rates of abstinence from alcohol
use [7,8], may result in a more acceptable process for
selecting and adapting existing EBTs - as well as devel-
oping AI/AN-specific interventions. Our analysis of the
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abuse programs strongly suggests that it is largely fac-
tors external to these programs that are driving the
move towards the use of EBTs. Unless there are changes
in internal factors, dissemination efforts will continue to
falter.
It may also be helpful to return to the IOM’so r i g i n a l
recommendations to improve connections between
researchers and service organizations [28]. These 12 pol-
icy recommendations spanned the following six key
areas: 1) linking research and practice; 2) linking
research findings, policy development, and treatment
implementation; 3) knowledge development; 4) dissemi-
nation and knowledge transfer; 5) consumer participa-
tion; and 6) community-based research collaboration.
The first, fifth and sixth areas - linking research and
practice as well as consumer participation and commu-
nity-based research collaboration - seem particularly
important areas if we are to shift from an externally-
mandated to an internally-driven process of change.
Such foci are also consistent with Greenhalgh et al.’s
[86] emphasis of the importance of linkage of the
‘knowledge purveyors’ (e.g., researchers), the ‘change
agency’ (e.g., funders of services), and the ‘user system’,
not only at the intervention dissemination and imple-
mentation stages, but at the intervention design stage as
well. Aarons et al.’s [101] findings regarding the public
mental health system in San Diego further underscore
the importance of integrating multiple stakeholders’ per-
spectives, input, and governance in order to better
understand and address the need to implement more
effective services.
And while the historical, political, cultural, and infra-
structural contexts for substance abuse services for AI/
AN communities are unique, many of the concerns we
identified (and potential solutions) are shared by non
AI/AN communities. These include concerns about the
lack of flexibility of many EBTs for use with clients who
are diverse both clinically and culturally as well as in
resource-poor clinical programs (characteristics of the
innovation), the heavy reliance on external mandates for
driving program change (external influences), and lim-
ited programmatic resources (structural and cultural
characteristics of potential organizational adopters).
While these shared concerns certainly raise the possibi-
lity of enhancing national approaches to improving sub-
stance abuse services so that they are more effective for
programs serving both AI/AN and non-AI/AN commu-
nities, it is important that we not lose sight of the dis-
tinctive characteristics of AI/AN communities and the
programs that serve them and that these will likely
require the development of tribally-specific approaches
(e.g., the resurgence in interests in AI/AN traditions and
knowledge as well as the importance of tribal
sovereignty). Similarly, the issues noted here for sub-
stance abuse services in AI/AN communities are likely
comparable for mental health services as well as services
for chronic health conditions that include cognitive
behavioral techniques for supporting behavior change (e.
g., the Healthy Heart Program for reducing the risks of
diabetes-related cardiovascular disease [105]). An
exploration of these issues for these other aspects of the
health care systems serving AI/AN people would be a
worthwhile exercise.
The extent to which these issues are comparable to
other indigenous communities (e.g.,t h eM a o r ip e o p l eo f
New Zealand, First Nations people in Canada, Khosian
people of Southern Africa) is more complex and intri-
guing than it might appear at first glance. As these
groups share parallel histories of European colonization
and control, we would certainly expect some similarities
in the perceptions and use of EBTs. For example, publi-
cations regarding substance abuse and mental health
treatment for the Maori suggest there are indeed similar
concerns about the cultural adaptation of standard treat-
ments [106,107] and there are efforts such as the Healing
our Spirit Worldwide that aims at linking the efforts of
indigenous groups internationally [108]. However, it is
equally important to note each of these indigenous com-
munities is also quite distinct with important differences
in their histories and contemporary circumstances. For
example, tribal sovereignty is an important factor in how
these issues have unfolded for AI/AN people as we have
noted in this paper, but the legal status of indigenous
peoples varies enormously from country to country
[109-111]. Finally, the countries within which these indi-
genous communities are embedded have markedly differ-
ent health care systems and have varying approaches to
substance abuse treatment [112,113]. It is likely that the
complex interactions of history, contemporary status,
and health care systems result in important differences in
how EBTs are perceived and used. Therefore the issues
described in this debate should be extended to other
indigenous populations with considerable caution.
This controversy also complicates research efforts in
this area - including our own. However, we came out of
our Advisory Board discussions with a much stronger
understanding of this controversy and how best to pro-
ceed to assure that our research is an accurate reflection
of the environment for dissemination of EBTs to sub-
stance abuse programs for AI/AN communities. This
movement from expert opinion (as reflected in this
paper) to empirical evidence promises to illuminate,
enhance, and provide a more solid foundation in efforts
to improve the quality of substance abuse services for
AI/AN communities, and enrich our national conversa-
tions regarding EBTs and Evidence-Based Practices for
all Americans.
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aEuro-American treatments include those from the
biomedical and behavioral sciences as well as those
emerging from other aspects of Euro-American culture
(e.g., 12-step programs).
bThere is no scholarly history of the substance abuse
services in AI/AN communities. The information here
was garnered from the contributions of Gordon Bel-
court, Raymond Daw, Candace Fleming, and Kathy
Masis to this manuscript, all of whom were active parti-
cipants in the development of these services.
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